Latham & Watkins advised Cheplapharm Arzneimittel on a private placement of 390 million senior secured notes, which refinances debt following its term loan B financing and its partnership with Sanofi.
Tags :latham & watkins
Latham & Watkins has advised the selling shareholder group of SK Pharma Logistics GmbH, including Syz Capital, Saturnus Capital and the company's founder, on the sale of the German healthcare logistics provider to Arcus European
Freshfields advised the initial purchasers, led by BNP Paribas, Deutsche Bank and ING, on Grünenthal's €850 million high-yield bond offering, comprising senior secured notes and floating rate notes due 2032.
Latham & Watkins has advised Cheplapharm on a strategic partnership with Sanofi, under which Cheplapharm will acquire a portfolio of 20 mature medicines and three manufacturing sites worldwide, while Sanofi will take a 26.4% equity stake in
Latham & Watkins has advised technology-focused investment firm Battery Ventures on its acquisition of a majority stake in the Sustainability at Work Group, a company that develops digital certification systems and provides consulting services across
Banking & Finance
Deal & transactions
Latham & Watkins advises Crescent on Infravadis’ debt financing
Latham & Watkins LLP has advised Crescent, an alternative investment firm, on a senior secured private debt financing for Infravadis, a tech-enabled underground infrastructure maintenance platform and portfolio company of Oakley Capital.
Latham & Watkins advised the arrangers in connection with a debut €535 million EUR Term Loan B and a €100 million revolving credit facility for Autodoc, a European online retailer of automotive spare parts and accessories. As
Latham & Watkins has advised Lowell, a credit management services provider, on the sale of its DACH operations to funds managed by Orlando Capital. The carve-out spans Lowell's businesses in Germany, Austria and Switzerland, which
Latham & Watkins advised CordenPharma, a pharmaceutical contract development and manufacturing organization (CDMO) and a portfolio company of Astorg, on its acquisition of AmbioPharm. The transaction expands CordenPharma’s upstream and downstream peptide manufacturing footprint
Latham & Watkins advised Westconnect, a German fibre joint venture between Igneo Infrastructure Partners and Westenergie AG, on its €1.2 billion capital raise. The additional €1.2 billion comprises debt financing from new and existing financing partners, as
